RS51925B - Derivati cikličnih amida, njihovo dobijanje i upotreba kao antitrombotskih agenasa - Google Patents

Derivati cikličnih amida, njihovo dobijanje i upotreba kao antitrombotskih agenasa

Info

Publication number
RS51925B
RS51925B RS20110371A RSP20110371A RS51925B RS 51925 B RS51925 B RS 51925B RS 20110371 A RS20110371 A RS 20110371A RS P20110371 A RSP20110371 A RS P20110371A RS 51925 B RS51925 B RS 51925B
Authority
RS
Serbia
Prior art keywords
salt
acid
compound
sulfonyl
chloronaphthalen
Prior art date
Application number
RS20110371A
Other languages
English (en)
Serbian (sr)
Inventor
K. Kubo
Y. Imaeda
Original Assignee
Takeda Pharmaceutical Company Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Company Limited filed Critical Takeda Pharmaceutical Company Limited
Publication of RS51925B publication Critical patent/RS51925B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C07D211/76—Oxygen atoms attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
RS20110371A 2004-05-21 2005-05-20 Derivati cikličnih amida, njihovo dobijanje i upotreba kao antitrombotskih agenasa RS51925B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004152000 2004-05-21

Publications (1)

Publication Number Publication Date
RS51925B true RS51925B (sr) 2012-02-29

Family

ID=34968275

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20110371A RS51925B (sr) 2004-05-21 2005-05-20 Derivati cikličnih amida, njihovo dobijanje i upotreba kao antitrombotskih agenasa

Country Status (26)

Country Link
US (4) US7745623B2 (cg-RX-API-DMAC7.html)
EP (2) EP1748985B1 (cg-RX-API-DMAC7.html)
JP (2) JP4129047B2 (cg-RX-API-DMAC7.html)
KR (1) KR101248637B1 (cg-RX-API-DMAC7.html)
CN (2) CN1989104B (cg-RX-API-DMAC7.html)
AT (1) ATE513813T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005245298B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0511186A (cg-RX-API-DMAC7.html)
CA (1) CA2567506C (cg-RX-API-DMAC7.html)
CY (1) CY1111850T1 (cg-RX-API-DMAC7.html)
DK (1) DK1748985T3 (cg-RX-API-DMAC7.html)
ES (1) ES2368155T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20110640T1 (cg-RX-API-DMAC7.html)
IL (1) IL178896A (cg-RX-API-DMAC7.html)
MX (1) MXPA06013243A (cg-RX-API-DMAC7.html)
MY (1) MY154461A (cg-RX-API-DMAC7.html)
NO (1) NO20065929L (cg-RX-API-DMAC7.html)
NZ (1) NZ550985A (cg-RX-API-DMAC7.html)
PH (1) PH12012501331A1 (cg-RX-API-DMAC7.html)
PL (1) PL1748985T3 (cg-RX-API-DMAC7.html)
PT (1) PT1748985E (cg-RX-API-DMAC7.html)
RS (1) RS51925B (cg-RX-API-DMAC7.html)
RU (1) RU2361861C2 (cg-RX-API-DMAC7.html)
SI (1) SI1748985T1 (cg-RX-API-DMAC7.html)
TW (1) TWI396686B (cg-RX-API-DMAC7.html)
WO (1) WO2005113504A1 (cg-RX-API-DMAC7.html)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030187023A1 (en) * 2000-07-17 2003-10-02 Keiji Kubo Sulfone derivatives, process for their production and use thereof
WO2004048363A1 (ja) * 2002-11-22 2004-06-10 Takeda Pharmaceutical Company Limited イミダゾール誘導体、その製造法および用途
TWI396686B (zh) * 2004-05-21 2013-05-21 Takeda Pharmaceutical 環狀醯胺衍生物、以及其製品和用法
US7592427B2 (en) * 2005-11-28 2009-09-22 Zymogenetics, Inc. Antibodies to IL-21 receptor
US20110045028A1 (en) * 2006-11-30 2011-02-24 Takeda Pharmaceutical Company Limited Sustained release preparation
TW201014850A (en) 2008-09-25 2010-04-16 Takeda Pharmaceutical Solid pharmaceutical composition
JP5535931B2 (ja) 2008-10-27 2014-07-02 武田薬品工業株式会社 二環性化合物
US8557805B2 (en) 2008-12-29 2013-10-15 Takeda Pharmaceutical Company Limited Fused ring compound and use thereof
UY32395A (es) 2009-01-27 2010-08-31 Takeda Pharmaceutical Compuesto con anillo fusionado y su uso
GEP20135940B (en) 2009-04-30 2013-10-10 Takeda Pharmaceuticals Co Solid preparations
JP5657578B2 (ja) 2009-06-09 2015-01-21 武田薬品工業株式会社 新規な縮合環化合物およびその用途
CN102548556A (zh) 2009-07-28 2012-07-04 武田药品工业株式会社 片剂
US8221489B2 (en) * 2009-08-20 2012-07-17 Stentys Device and method for treating a body lumen
AU2011246004A1 (en) 2010-04-27 2012-11-29 Takeda Pharmaceutical Company Limited Bicyclic compound derivatives and their use as ACC inhibitors.
GEP20146195B (en) 2010-06-16 2014-11-10 Takeda Pharmaceuticals Co Crystal of amide compound
EA026142B1 (ru) 2010-07-23 2017-03-31 Такеда Фармасьютикал Компани Лимитед Конденсированное гетероциклическое соединение и его применение
EP2617726A4 (en) 2010-09-17 2014-05-14 Takeda Pharmaceutical DIABETES THERAPEUTIC
KR20140001965A (ko) 2010-11-30 2014-01-07 다케다 야쿠힌 고교 가부시키가이샤 바이시클릭 화합물
JP5945545B2 (ja) 2011-02-17 2016-07-05 武田薬品工業株式会社 光学活性なジヒドロベンゾフラン誘導体の製造法
WO2013061962A1 (ja) 2011-10-24 2013-05-02 武田薬品工業株式会社 二環性化合物
US9365540B2 (en) 2012-01-12 2016-06-14 Takeda Pharmaceutical Company Limited Benzimidazole derivatives as MCH receptor antagonists
US9181186B2 (en) 2012-02-13 2015-11-10 Takeda Pharmaceutical Company Limited Aromatic ring compound
WO2013122028A1 (ja) 2012-02-13 2013-08-22 武田薬品工業株式会社 芳香環化合物
EP2814466B1 (en) 2012-02-15 2018-12-26 Takeda Pharmaceutical Company Limited Tablet comprising 1-(4-methoxybutyl)-n-(2-methylpropyl)-n-[(3s,5r)-5-(morpholin-4-ylcarbonyl)piperidin-3-yl]-1h-benzimidazole-2-carboxamide or a salt thereof
ES2640258T3 (es) 2012-02-24 2017-11-02 Takeda Pharmaceutical Company Limited Compuesto anular aromático como inhibidor de grelina o-aciltransferasa
JPWO2013147026A1 (ja) 2012-03-29 2015-12-14 武田薬品工業株式会社 芳香環化合物
EP2848622A4 (en) 2012-05-10 2015-11-04 Takeda Pharmaceutical Aromatic ring compound
JPWO2013168759A1 (ja) 2012-05-10 2016-01-07 武田薬品工業株式会社 芳香環化合物
AR092843A1 (es) 2012-06-05 2015-05-06 Takeda Pharmaceuticals Co Preparacion solida
JP2015127299A (ja) 2012-07-19 2015-07-09 武田薬品工業株式会社 固形製剤
EP2889291A4 (en) 2012-08-24 2015-10-14 Takeda Pharmaceutical HETEROCYCLIC CONNECTION
CN103936763B (zh) * 2013-01-18 2017-10-31 中国科学院上海药物研究所 噁唑烷酮类化合物及其制备方法和用途
JP6247697B2 (ja) 2013-03-14 2017-12-13 武田薬品工業株式会社 スピロアゼチジンイソキサゾール誘導体及びそのｓｓｔｒ５アンタゴニストとしての使用
WO2014165816A1 (en) 2013-04-05 2014-10-09 North Carolina Central University Compounds useful for the treatment of metabolic disorders and synthesis of the same
TW201536767A (zh) 2013-07-09 2015-10-01 Takeda Pharmaceutical 雜環化合物
SMT201800339T1 (it) 2013-08-09 2018-09-13 Takeda Pharmaceuticals Co Composto aromatico
JO3442B1 (ar) 2013-10-07 2019-10-20 Takeda Pharmaceuticals Co مضادات ذات نوع فرعي من مستقبل سوماتوستاتين 5 (sstr5)
US9346776B2 (en) 2014-02-13 2016-05-24 Takeda Pharmaceutical Company Limited Fused heterocyclic compound
US9428470B2 (en) 2014-02-13 2016-08-30 Takeda Pharmaceutical Company Limited Heterocyclic compound
US10100027B2 (en) * 2014-09-26 2018-10-16 Changzhou Yinsheng Pharmaceutical Co., Ltd. Benzofuran analogue as NS4B inhibitor
EP3524596B1 (en) 2014-12-23 2020-09-09 Crossing S.r.l. Reagents comprising 2-halo-4,6-dialkoxy-1,3,5-triazines in the presence of amines and their use in a stabilization method.
JOP20180028A1 (ar) 2017-03-31 2019-01-30 Takeda Pharmaceuticals Co مركب ببتيد
AR111199A1 (es) 2017-03-31 2019-06-12 Takeda Pharmaceuticals Co Compuesto aromático agonista de gpr40
EP3604267A4 (en) 2017-03-31 2020-12-16 Takeda Pharmaceutical Company Limited Aromatic compound
EP3654968B1 (en) 2017-07-17 2023-08-16 Merck Sharp & Dohme LLC Metallo-beta-lactamase inhibitors and methods of use thereof
MY205468A (en) 2018-03-23 2024-10-22 Carmot Therapeutics Inc Modulators of g-protein coupled receptors
TW202024028A (zh) 2018-08-27 2020-07-01 日商思可海雅藥品股份有限公司 苯甲酸酯化合物
US20220016215A1 (en) 2018-09-24 2022-01-20 Takeda Phaarmaceutical Company Limited Gip receptor agonist peptide compounds and uses thereof
WO2020067557A2 (en) 2018-09-24 2020-04-02 Takeda Pharmaceutical Company Limited Gip receptor agonist peptide compounds and uses thereof
PH12022552056A1 (en) 2020-02-07 2024-02-12 Gasherbrum Bio Inc Heterocyclic glp-1 agonists
KR20220157409A (ko) 2020-03-25 2022-11-29 다케다 야쿠힌 고교 가부시키가이샤 Gip 수용체 작용제 펩티드 화합물 및 이의 용도
JP2023519446A (ja) 2020-03-25 2023-05-10 武田薬品工業株式会社 Ｇｉｐ受容体アゴニストペプチド化合物のｑｄ投薬及びその使用
MX2023013492A (es) 2021-05-13 2024-02-29 Carmot Therapeutics Inc Moduladores de los receptores acoplados a proteinas g.
JP2025509281A (ja) 2022-03-09 2025-04-11 ガシャーブラム・バイオ・インコーポレイテッド ヘテロ環式ｇｌｐ－１アゴニスト
JP2025510741A (ja) 2022-03-21 2025-04-15 ガシャーブラム・バイオ・インコーポレイテッド ヘテロ環式ｇｌｐ－１アゴニスト
WO2023198140A1 (en) 2022-04-14 2023-10-19 Gasherbrum Bio, Inc. Heterocyclic glp-1 agonists
WO2024125602A1 (en) 2022-12-15 2024-06-20 Gasherbrum Bio, Inc. Salts and solid forms of a compound having glp-1 agonist activity
CN120693338A (zh) 2022-12-22 2025-09-23 加舒布鲁姆生物公司 杂环的glp-1激动剂
EP4638440A1 (en) 2022-12-22 2025-10-29 Gasherbrum Bio, Inc. Heterocyclic glp-1 agonists
EP4665730A1 (en) 2023-02-16 2025-12-24 Gasherbrum Bio, Inc. Heterocyclic glp-1 agonists
US20250019389A1 (en) 2023-06-30 2025-01-16 Gasherbrum Bio, Inc. Heterocyclic agonists
TW202521528A (zh) 2023-07-13 2025-06-01 美商雅空嘉閣生物公司 化合物、組合物及方法
AR133241A1 (es) 2023-07-13 2025-09-10 Aconcagua Bio Inc Compuestos, composiciones y métodos
WO2025045208A1 (en) 2023-08-31 2025-03-06 Gasherbrum Bio, Inc. Heteroaryl-heterocycloalkyl-based glp-1 agonists
WO2025137307A1 (en) 2023-12-20 2025-06-26 Gasherbrum Bio, Inc. Heterocyclic glp-1 agonists
WO2025154021A1 (en) 2024-01-19 2025-07-24 Takeda Pharmaceutical Company Limited Improved gip receptor agonist peptide compounds and uses thereof
WO2025154020A1 (en) 2024-01-19 2025-07-24 Takeda Pharmaceutical Company Limited Improved gip receptor agonist peptide compounds and uses thereof
WO2025171341A2 (en) 2024-02-08 2025-08-14 Aconcagua Bio, Inc. Compounds and compositions for treating conditions associated with calcitonin receptor and/or amylin receptor activity
WO2025171340A1 (en) 2024-02-08 2025-08-14 Aconcagua Bio, Inc. The treatment of calcitonin- and/or amylin-receptor associated conditions
WO2025189141A1 (en) 2024-03-08 2025-09-12 Annapurna Bio, Inc. Methods for treating obesity and increasing weight loss

Family Cites Families (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US270488A (en) * 1883-01-09 Drilling apparatus
US2201270A (en) * 1936-04-17 1940-05-21 Mcintyre John Taylor Apparatus for allaying dust from rock drills
US2946565A (en) * 1953-06-16 1960-07-26 Jersey Prod Res Co Combination drilling and testing process
US2849214A (en) * 1954-09-02 1958-08-26 Gulf Research Development Co Borehole drilling apparatus for preventing lost circulation
US3497020A (en) * 1968-05-20 1970-02-24 Archer W Kammerer Jr System for reducing hydrostatic pressure on formations
JPS5011391B1 (cg-RX-API-DMAC7.html) * 1970-07-21 1975-04-30
SE355840B (cg-RX-API-DMAC7.html) * 1971-09-08 1973-05-07 Atlas Copco Ab
FR2228301B1 (cg-RX-API-DMAC7.html) * 1973-05-03 1977-10-14 Ibm
US4147786A (en) * 1976-02-02 1979-04-03 Ciba-Geigy Corporation 1-Indolylalkyl-3-or 4-trimethyleneurido-piperidines
EP0000485A1 (de) 1977-07-08 1979-02-07 Ciba-Geigy Ag Piperidino-propanole, ihre Herstellung und pharmazeutische Präparate die diese enthalten
FI782133A7 (fi) * 1977-07-08 1979-01-09 Ciba Geigy Ag Piperidino-propanoler och foerfarande foer deras framstaellning
US4329348A (en) * 1979-02-26 1982-05-11 Ciba-Geigy Corporation N-Oxacyclic-alkylpiperidines as psychostimulants
US4630691A (en) * 1983-05-19 1986-12-23 Hooper David W Annulus bypass peripheral nozzle jet pump pressure differential drilling tool and method for well drilling
US4534426A (en) * 1983-08-24 1985-08-13 Unique Oil Tools, Inc. Packer weighted and pressure differential method and apparatus for Big Hole drilling
US4567954A (en) * 1983-12-02 1986-02-04 Norton Christensen, Inc. Replaceable nozzles for insertion into a drilling bit formed by powder metallurgical techniques and a method for manufacturing the same
US4695575A (en) * 1984-11-13 1987-09-22 Janssen Pharmaceutica, N.V. 4-[(bicycle heterocyclyl)-methyl and -hetero]-piperidines
ZA928276B (en) 1991-10-31 1993-05-06 Daiichi Seiyaku Co Aromatic amidine derivates and salts thereof.
US5902272A (en) * 1992-01-07 1999-05-11 Arthrocare Corporation Planar ablation probe and method for electrosurgical cutting and ablation
US5595872A (en) * 1992-03-06 1997-01-21 Bristol-Myers Squibb Company Nucleic acids encoding microsomal trigyceride transfer protein
ZA931601B (en) 1992-03-06 1993-10-05 Squibb & Sons Inc Microsomal triglyceride transfer protein
US5355967A (en) * 1992-10-30 1994-10-18 Union Oil Company Of California Underbalance jet pump drilling method
GB9321557D0 (en) 1992-11-03 1993-12-08 Zeneca Ltd Carboxamide derivatives
GB9312806D0 (en) 1993-06-22 1993-08-04 Boots Co Plc Therapeutic agents
GB9317104D0 (en) * 1993-08-17 1993-09-29 Zeneca Ltd Therapeutic heterocycles
TW394760B (en) * 1993-09-07 2000-06-21 Hoffmann La Roche Novel Carboxamides, process for their preparation and pharmaceutical composition containing the same
IL112795A (en) * 1994-03-04 2001-01-28 Astrazeneca Ab Peptide derivatives as antithrombic agents their preparation and pharmaceutical compositions containing them
US5456326A (en) * 1994-04-18 1995-10-10 Exxon Production Research Company Apparatus and method for installing open-ended tubular members axially into the earth
IL115420A0 (en) 1994-09-26 1995-12-31 Zeneca Ltd Aminoheterocyclic derivatives
AU701127B2 (en) 1994-10-27 1999-01-21 Merck & Co., Inc. Muscarine antagonists
DE69529770T2 (de) 1994-12-02 2003-12-24 Yamanouchi Pharmaceutical Co., Ltd. Neues amidinonaphthylderivat oder dessen salz
GB9508786D0 (en) * 1995-04-29 1995-06-21 Zeneca Ltd Substituted heterocycles
EP0828754B1 (en) 1995-05-29 2005-02-02 Pfizer Inc. Dipeptides which promote release of growth hormone
US5612353A (en) 1995-06-07 1997-03-18 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds
US5849759A (en) 1995-12-08 1998-12-15 Berlex Laboratories, Inc. Naphthyl-substituted benzimidazole derivatives as anti-coagulants
GB9602294D0 (en) 1996-02-05 1996-04-03 Zeneca Ltd Heterocyclic compounds
KR100512671B1 (ko) 1996-11-27 2005-09-07 아벤티스 파마슈티칼스 인크. 항 Ｘａ 활성을 지닌 화합물 및 혈소판 응집 길항제 화합물을포함하는 약제학적 조성물
EP0986551B1 (en) * 1997-05-30 2006-08-02 Takeda Pharmaceutical Company Limited Sulfonamide derivatives, their production and use
FR2764511B1 (fr) * 1997-06-13 2000-09-08 Sanofi Sa Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire
GB9715895D0 (en) 1997-07-29 1997-10-01 Zeneca Ltd Heterocyclic compounds
CA2310330A1 (en) 1997-11-20 1999-06-03 Teijin Limited Biphenylamidine derivatives
ZA9810550B (en) 1997-11-21 1999-05-16 Schering Corp Substituted oximes as neurokinin antagonists
AU1692399A (en) 1997-12-26 1999-07-19 Mochida Pharmaceutical Co., Ltd. Aromatic compounds having cyclic amino or salts thereof
EP1054005A4 (en) 1998-02-05 2003-02-05 Takeda Chemical Industries Ltd SULPHONAMIDE DERIVATIVES, METHOD FOR THE PRODUCTION AND THEIR USE
DE69919149D1 (de) * 1998-04-10 2004-09-09 Japan Tobacco Inc Amidin-verbindungen
US6129152A (en) * 1998-04-29 2000-10-10 Alpine Oil Services Inc. Rotating bop and method
GB9809349D0 (en) 1998-05-02 1998-07-01 Zeneca Ltd Heterocyclic derivatives
US6423519B1 (en) * 1998-07-15 2002-07-23 Gpc Biotech Inc. Compositions and methods for inhibiting fungal growth
CA2340100A1 (en) 1998-08-11 2000-02-24 Daiichi Pharmaceutical Co., Ltd. Novel sulfonyl derivatives
JP2000080046A (ja) 1998-09-03 2000-03-21 Dai Ichi Seiyaku Co Ltd 多臓器障害の予防・治療剤
EP1115396A4 (en) 1998-09-25 2002-05-22 Sunol Molecular Corp PHARMACEUTICALLY ACTIVE COMPOUNDS, AND METHODS OF USE THEREOF
US7217714B1 (en) 1998-12-23 2007-05-15 Agouron Pharmaceuticals, Inc. CCR5 modulators
CA2355886C (en) 1998-12-23 2006-10-31 Schering Corporation Substituted oximes and hydrazones as neurokinin antagonists
US6204265B1 (en) * 1998-12-23 2001-03-20 Schering Corporation Substituted oximes and hydrazones as neurokinin antagonists
CA2383492A1 (en) 1999-06-22 2000-12-28 Takeda Chemical Industries, Ltd. Acylhydrazine derivatives, their production and use
EP1191028B1 (en) 1999-06-30 2004-11-03 Mochida Pharmaceutical Co., Ltd. Tricyclic compounds having spiro union
HK1054227A1 (zh) 1999-07-28 2003-11-21 阿温蒂斯药物制品公司 取代的氧代氮杂杂环基化合物
AU7354900A (en) 1999-09-09 2001-04-10 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
EP1242366A1 (en) 1999-12-15 2002-09-25 Axys Pharmaceuticals, Inc. Salicylamides as serine protease and factor xa inhibitors
US6723091B2 (en) * 2000-02-22 2004-04-20 Gyrus Medical Limited Tissue resurfacing
US6629974B2 (en) * 2000-02-22 2003-10-07 Gyrus Medical Limited Tissue treatment method
AR033517A1 (es) 2000-04-08 2003-12-26 Astrazeneca Ab Derivados de piperidina, proceso para su preparacion y uso de estos derivados en la fabricacion de medicamentos
US20030187023A1 (en) * 2000-07-17 2003-10-02 Keiji Kubo Sulfone derivatives, process for their production and use thereof
JP2002201178A (ja) * 2000-07-17 2002-07-16 Takeda Chem Ind Ltd スルホン誘導体、その製造法及び用途
US6511973B2 (en) * 2000-08-02 2003-01-28 Bristol-Myers Squibb Co. Lactam inhibitors of FXa and method
WO2002026720A2 (en) 2000-09-29 2002-04-04 Millennium Pharmaceuticals, Inc. PIPERAZINE BASED INHIBITORS OF FACTOR Xa
ATE332106T1 (de) * 2000-10-18 2006-07-15 Mattioli Eng Ltd Apparat zur wiederherstellung von hautflächen mit plasma
FR2819511A1 (fr) 2001-01-18 2002-07-19 Servier Lab Nouveaux composes azepane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2002068407A1 (en) 2001-02-28 2002-09-06 Yamanouchi Pharmaceutical Co., Ltd. Benzimidazole compound
WO2003010160A2 (en) 2001-07-26 2003-02-06 Eli Lilly And Company 1-glycinyl-4 (methylpiperidin-4-yl) piperazines and -piperridines as factor xa antagonists
US6877571B2 (en) * 2001-09-04 2005-04-12 Sunstone Corporation Down hole drilling assembly with independent jet pump
US7115741B2 (en) 2001-09-06 2006-10-03 Levy Daniel E 4-thieno[2,3-D]pyrimidin-4-YL piperazine compounds
KR100909141B1 (ko) 2001-09-21 2009-07-23 브리스톨-마이어스스퀴브컴파니 인자 Ｘａ 억제제로서의 락탐-함유 화합물 및 그의 유도체
JP4563675B2 (ja) * 2001-10-12 2010-10-13 ハイ・ポイント・ファーマスーティカルズ、エルエルシー 置換ピペリジン類、およびヒスタミンｈ３受容体関連疾患の治療のためのその使用
DE10155075A1 (de) * 2001-11-09 2003-05-22 Merck Patent Gmbh Cyclische Sulfonamide
DE60330847D1 (de) * 2002-03-28 2010-02-25 Mitsubishi Tanabe Pharma Corp Benzofuranderivat
TW200307667A (en) * 2002-05-06 2003-12-16 Bristol Myers Squibb Co Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors
DE10229070A1 (de) 2002-06-28 2004-01-15 Merck Patent Gmbh Phenylderivate 5
US20040006490A1 (en) 2002-07-08 2004-01-08 Gingrich Mark A. Prescription data exchange system
WO2004031145A2 (en) * 2002-10-02 2004-04-15 Bristol-Myers Squibb Company Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors
WO2004035579A1 (ja) 2002-10-15 2004-04-29 Takeda Pharmaceutical Company Limited イミダゾピリジン誘導体、その製造法および用途
WO2004048363A1 (ja) 2002-11-22 2004-06-10 Takeda Pharmaceutical Company Limited イミダゾール誘導体、その製造法および用途
EP1597256A1 (en) * 2003-02-21 2005-11-23 Pfizer Inc. N-heterocyclyl-substituted amino-thiazole derivatives as protein kinase inhibitors
US6899188B2 (en) * 2003-03-26 2005-05-31 Sunstone Corporation Down hole drilling assembly with concentric casing actuated jet pump
WO2005087266A1 (en) 2004-03-05 2005-09-22 Vddi Pharmaceuticals Combination therapy for inhibition of platelet aggregation
TWI396686B (zh) * 2004-05-21 2013-05-21 Takeda Pharmaceutical 環狀醯胺衍生物、以及其製品和用法
US7988933B2 (en) 2006-09-01 2011-08-02 Siemens Healthcare Diagnostics Inc. Identification system for a clinical sample container
KR100906250B1 (ko) 2006-09-04 2009-07-07 주식회사 엘지화학 바인더로서 고중합도 폴리비닐알콜과 폴리비닐피롤리돈의혼합물을 포함하는 전극 합제 및 이를 포함하는 리튬이차전지

Also Published As

Publication number Publication date
TW200600508A (en) 2006-01-01
KR101248637B1 (ko) 2013-03-28
BRPI0511186A (pt) 2007-12-04
US20080255362A1 (en) 2008-10-16
EP1748985B1 (en) 2011-06-22
TWI396686B (zh) 2013-05-21
CA2567506C (en) 2013-06-18
US20100160629A1 (en) 2010-06-24
ATE513813T1 (de) 2011-07-15
MY154461A (en) 2015-06-30
JP2008163030A (ja) 2008-07-17
US20070244118A1 (en) 2007-10-18
PL1748985T3 (pl) 2011-11-30
EP1748985A1 (en) 2007-02-07
EP2208726B1 (en) 2014-08-20
AU2005245298A1 (en) 2005-12-01
CN1989104A (zh) 2007-06-27
RU2006145449A (ru) 2008-06-27
IL178896A (en) 2012-07-31
IL178896A0 (en) 2007-03-08
KR20070021205A (ko) 2007-02-22
US20080255352A1 (en) 2008-10-16
WO2005113504A1 (en) 2005-12-01
HK1100666A1 (en) 2007-09-28
CA2567506A1 (en) 2005-12-01
CN1989104B (zh) 2011-07-13
CY1111850T1 (el) 2015-10-07
US8697865B2 (en) 2014-04-15
CN102093285A (zh) 2011-06-15
EP2208726A1 (en) 2010-07-21
MXPA06013243A (es) 2007-02-08
PH12012501331A1 (en) 2013-06-17
DK1748985T3 (da) 2011-08-29
RU2361861C2 (ru) 2009-07-20
JP2008500385A (ja) 2008-01-10
JP4362535B2 (ja) 2009-11-11
AU2005245298B2 (en) 2011-04-07
ES2368155T3 (es) 2011-11-14
SI1748985T1 (sl) 2011-08-31
HRP20110640T1 (hr) 2011-10-31
US7745623B2 (en) 2010-06-29
JP4129047B2 (ja) 2008-07-30
CN102093285B (zh) 2013-10-16
PT1748985E (pt) 2011-07-29
NO20065929L (no) 2007-02-19
NZ550985A (en) 2011-02-25

Similar Documents

Publication Publication Date Title
RS51925B (sr) Derivati cikličnih amida, njihovo dobijanje i upotreba kao antitrombotskih agenasa
JP4053597B2 (ja) 置換ｎ―［（アミノイミノメチル又はアミノメチル）フェニル］プロピルアミド
AU776053B2 (en) Diazepan derivatives or salts thereof
JPH072851A (ja) ５員複素環化合物、それらの調製方法及びこれらの化合物を含む医薬組成物
JP2001512103A (ja) 第ｘａ因子を阻害する複素環誘導体
DE69921994T2 (de) Heterozyklische verbindungen mit faktor xa hemmender wirkung
EA001739B1 (ru) Замещенные n-[(аминоиминометил)фенилалкил]азагетероцикламиды сульфоновых кислот
KR20150136294A (ko) 인자 ＸＩａ 억제 활성을 가지는 신규한 화합물
DE69923444T2 (de) Heterozyklische verbindungen mit faktor xa hemmender wirkung
JPWO2002083649A1 (ja) 新規イミダゾリジンジオン誘導体およびその医薬用途
JP5796872B2 (ja) 第Ｘａ因子阻害剤の結晶性塩
HK1100666B (en) Cyclic amide derivatives, and their production and use as antithrombotic agents
JP3174767B2 (ja) 選択的トロンビン抑制剤として有用な芳香族アミジン誘導体
WO2007055183A1 (ja) ベンゼン誘導体又はその塩
JP2006008664A (ja) イミダゾール誘導体、その製造法及び用途
JP7458984B2 (ja) テトラヒドロイソキノリン系誘導体、その製造方法及び用途
JP3162587B2 (ja) 新規複素環誘導体及び血小板凝集阻害剤
KR20060130189A (ko) 쿠마린 유도체 및 그의 용도
WO2016189881A1 (en) Pharmaceutical composition for treating cerebral infarction
HK40031655A (en) Tetrahydroisoquinoline derivative, preparation method therefor and uses thereof
JPWO1999033805A1 (ja) 環状アミノ基を有する芳香族化合物またはその塩
HK1146041A (en) Cyclic amide derivatives, and their production and use as antithrombotic agents
JP2004123538A (ja) ジフェニルチアゾリジンジオン誘導体およびその医薬用途
CZ2000293A3 (cs) Heterocyklické deriváty, které inhibují faktor Xa